Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2012
04/10/2012US8153172 Composition to enhance the bioavailability of curcumin
04/10/2012US8153161 Medicament-containing particle and a solid preparation containing the particle
04/10/2012US8153160 Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist
04/10/2012US8153159 Modafinil modified release pharmaceutical compositions
04/10/2012US8153158 Tissue substitutes comprising stem cells and reduced ceria
04/10/2012US8153157 Porous cellulose aggregate and molding composition thereof
04/10/2012US8153156 Hydrogel nanocompsites for ophthalmic applications
04/10/2012US8153155 Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery system
04/10/2012US8153154 Arginine-conjugated bioreducible poly(disulfide amine) polymers for gene delivery systems
04/10/2012US8153153 Pharmaceutical composition of nanoparticles for protein drug delivery
04/10/2012US8153152 Oral drug delivery system
04/10/2012US8153151 Composition and method for controlling drug delivery from silicone adhesive blends
04/10/2012US8153142 Skin treatment composition
04/10/2012US8153141 Immunostimulatory G, U-containing oligoribonucleotides
04/10/2012US8153111 Photo-triggered release of active substances from dendrimer-photosensitizer complexes
04/10/2012US8153110 Environment-responding siRNA carrier using disulfide-cross-linked polymeric micelle
04/10/2012US8153105 Sunblock composition with photostabilizer and method of preparation
04/10/2012US8153104 Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
04/10/2012US8152793 Membrane shell of an implantable dosage system
04/10/2012CA2687078C Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives
04/10/2012CA2676003C Compositions of stable tiacumicins
04/10/2012CA2662967C Medicinal composition
04/10/2012CA2630304C Aqueous dispersions and solutions of difficult to dissolve compounds and methods of their preparation
04/10/2012CA2607098C Dispersible bosentan tablet
04/10/2012CA2567867C Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
04/10/2012CA2548897C Endoparasiticidal agents for topical application
04/10/2012CA2540052C Methylphenidate solution and associated methods of administration and production
04/10/2012CA2517679C Nanoparticulate meloxicam formulations
04/10/2012CA2514446C Composition comprising a mixture of active principles, and method of preparation
04/10/2012CA2514124C Absorption enhancing agents
04/10/2012CA2489828C Thermosensitive polymers and thermoreversible gels obtained from these polymers
04/10/2012CA2484375C Oral dosage forms comprising fenofibrate
04/10/2012CA2477857C Stabilized liquid polypeptide-containing pharmaceutical compositions
04/10/2012CA2474520C Solid alginate compositions for use in treating gastric disorders
04/10/2012CA2446506C Methods for treating delirium using glucocorticoid receptor-specific antagonists
04/10/2012CA2445408C Quinolone carboxylic acid compositions and related methods of treatment
04/10/2012CA2403704C Method for preparing high pressure/high shear dispersions containing physiologically active ingredients
04/10/2012CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof
04/10/2012CA2366027C Orally dispersible tablet with low friability and method for preparing same
04/10/2012CA2341580C Cosmetic or dermopharmaceutical composition in the form of beads and methods for preparing same
04/05/2012WO2012045090A2 Therapeutic use of a tlr agonist and combination therapy
04/05/2012WO2012045089A2 Methods for the treatment of allergic diseases
04/05/2012WO2012045072A2 Sugar-based dispersion
04/05/2012WO2012044939A2 Method of preparing a dry powder from a water bacteria extract-concentrate
04/05/2012WO2012044736A1 Monovalent metal cation dry powders for inhalation
04/05/2012WO2012044675A2 Emulsion method for preparing low residual solvent microparticles
04/05/2012WO2012044671A2 Method for removing residual organic solvent from microparticles
04/05/2012WO2012044638A1 Low molecular weight cationic lipids for oligonucleotide delivery
04/05/2012WO2012044140A1 Anti-tuberculosis preparation in tablet form and process for preparing same
04/05/2012WO2012043801A1 Patch
04/05/2012WO2012043709A1 Preparation for improving solubility of poorly soluble drug
04/05/2012WO2012043701A1 Transdermal absorption preparation
04/05/2012WO2012043700A1 Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
04/05/2012WO2012043696A1 Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
04/05/2012WO2012043680A1 水系皮膚外用剤aqueous topical preparation for use on skin
04/05/2012WO2012043393A1 Emulsion composition
04/05/2012WO2012043173A1 Method for producing gardenia blue pigment
04/05/2012WO2012042951A1 Atorbastatin-containing medicinal tablet
04/05/2012WO2012042372A1 Enteric coated, low- strength pancrelipase formulations
04/05/2012WO2012042371A2 Pharmaceutical composition
04/05/2012WO2012042331A1 Device for locally administering an active ingredient
04/05/2012WO2012042314A1 Treatment of tinnitus and related auditory dysfunctions
04/05/2012WO2012042224A2 Pharmaceutical composition
04/05/2012WO2012042197A2 Low dose pharmaceutical composition
04/05/2012WO2012042072A1 Topical amphotericin b formulations and production method thereof
04/05/2012WO2012042023A2 Cyclosporine emulsion
04/05/2012WO2012041995A1 Process for preparing a chemical structure having a phase partition, capable of generating a specific fluorescence spectrum and uses thereof
04/05/2012WO2012041966A1 Ovule for vaginal administration of arasertaconazole
04/05/2012WO2012041893A1 Hinged pad with soft edge
04/05/2012WO2012041788A1 Protective coatings for acidic active ingredients
04/05/2012WO2012041717A1 Use of magnesium stearate in dry powder formulations for inhalation
04/05/2012WO2012041488A1 Dry processing of atazanavir
04/05/2012WO2012041438A1 A process for treating sol-gel capsules
04/05/2012WO2012041328A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
04/05/2012WO2012041031A1 Compound composition for inhalation used for treating asthma
04/05/2012WO2012040938A1 Use of fucoxanthin in the preparation of product having neuroprotective effect associated with neurodegenerative disorder and improving memory
04/05/2012WO2012040919A1 Use of baicalein in manufacturing medicament for preventing and treating parkinson's disease
04/05/2012WO2012040915A1 Chinese medicinal composition for treating stomach pain of hepatogastric stagnated heat type, preparing method thereof
04/05/2012WO2012040832A1 Immunomodulatory nucleic acid composition comprising chitosan nanoparticles
04/05/2012WO2012020219A3 Formulations for infusion of type b lantibiotics
04/05/2012WO2012010980A3 Improved apparatus and process for making soft gel capsules
04/05/2012WO2012009080A3 Device for radiation-activated localized delivery of treatment agents
04/05/2012WO2012006398A3 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
04/05/2012WO2012003450A3 Biomatrix scaffolds
04/05/2012WO2012003181A3 Solid forms
04/05/2012WO2012000971A3 Compositions with a high active ingredient fraction of a mixture of chondroitin sulphate and glucosamine
04/05/2012WO2011163614A3 Methods of treatment for esophageal inflammation
04/05/2012WO2011162818A3 Lecithin carrier vesicles and methods of making the same
04/05/2012WO2011159550A3 Lysophosphatidic acid receptor antagonist and uses thereof
04/05/2012WO2011152805A3 Pharmaceutical composition comprising cefpodoxime proxetil and clavulanic acid
04/05/2012WO2011143254A3 Personal care formulations containing alkyl ketal esters and methods of manufacture
04/05/2012WO2011143201A3 Ratiometric combinatorial drug delivery
04/05/2012WO2011141488A3 Pharmaceutical compositions comprising hydromorphone and naloxone
04/05/2012WO2011141483A3 Stable pharmaceutical formulations containing an antihistaminic
04/05/2012WO2011140310A3 Povidone-iodine topical composition
04/05/2012WO2011140274A3 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
04/05/2012WO2011140136A3 Drug delivery coating and devices
04/05/2012WO2011139899A3 Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
04/05/2012WO2011139838A3 Intranasal formulations
04/05/2012WO2011139478A3 High shear application in medical therapy
1 ... 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 ... 2991